https://www.ktvb.com/article/news/health/coronavirus/health-experts-excited-about-monoclonal-covid-treatment/277-c37309a7-9e2d-452c-9247-fa160b80ee29The U.S. Food and Drug Administration (FDA) granted emergency use authorization to a new monoclonal treatment in December. It is the Astrazeneca Evusheld shot.
Unlike other monoclonal treatment, Evusheld is preventative, meaning the patient takes it before infection.
Evusheld is a two-part injection and can offer six months of protection, according to Idaho State Epidemiologist Dr. Christine Hahn. The FDA authorizes the treatment for people with "moderate to severely compromised immune systems" or anybody with "a history of severe adverse reactions to a COVID-19 vaccine" or any of the vaccine's ingredients.
(excerpt)
